1 Study Coverage 1.1 Eye Drug Product Introduction 1.2 Global Eye Drug Outlook 2017 VS 2022 VS 2028 1.2.1 Global Eye Drug Sales in US$ Million for the Year 2017-2028 1.2.2 Global Eye Drug Sales in Volume for the Year 2017-2028 1.3 United States Eye Drug Outlook 2017 VS 2022 VS 2028 1.3.1 United States Eye Drug Sales in US$ Million for the Year 2017-2028 1.3.2 United States Eye Drug Sales in Volume for the Year 2017-2028 1.4 Eye Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Eye Drug in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Eye Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Eye Drug Market Dynamics 1.5.1 Eye Drug Industry Trends 1.5.2 Eye Drug Market Drivers 1.5.3 Eye Drug Market Challenges 1.5.4 Eye Drug Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Eye Drug Market Segment by Type 2.1.1 Drops 2.1.2 Tablet & Capsule 2.2 Global Eye Drug Market Size by Type 2.2.1 Global Eye Drug Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Eye Drug Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Eye Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Eye Drug Market Size by Type 2.3.1 United States Eye Drug Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Eye Drug Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Eye Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Eye Drug Market Segment by Application 3.1.1 Glaucoma 3.1.2 Retinal Disease 3.1.3 Bacterial?Infection 3.1.4 Other 3.2 Global Eye Drug Market Size by Application 3.2.1 Global Eye Drug Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Eye Drug Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Eye Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Eye Drug Market Size by Application 3.3.1 United States Eye Drug Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Eye Drug Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Eye Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Eye Drug Competitor Landscape by Company 4.1 Global Eye Drug Market Size by Company 4.1.1 Top Global Eye Drug Manufacturers Ranked by Revenue (2021) 4.1.2 Global Eye Drug Revenue by Manufacturer (2017-2022) 4.1.3 Global Eye Drug Sales by Manufacturer (2017-2022) 4.1.4 Global Eye Drug Price by Manufacturer (2017-2022) 4.2 Global Eye Drug Concentration Ratio (CR) 4.2.1 Eye Drug Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Eye Drug in 2021 4.2.3 Global Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Eye Drug Manufacturing Base Distribution, Product Type 4.3.1 Global Eye Drug Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Eye Drug Product Type 4.3.3 Date of International Manufacturers Enter into Eye Drug Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Eye Drug Market Size by Company 4.5.1 Top Eye Drug Players in United States, Ranked by Revenue (2021) 4.5.2 United States Eye Drug Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Eye Drug Sales by Players (2020, 2021 & 2022) 5 Global Eye Drug Market Size by Region 5.1 Global Eye Drug Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Eye Drug Market Size in Volume by Region (2017-2028) 5.2.1 Global Eye Drug Sales in Volume by Region: 2017-2022 5.2.2 Global Eye Drug Sales in Volume Forecast by Region (2023-2028) 5.3 Global Eye Drug Market Size in Value by Region (2017-2028) 5.3.1 Global Eye Drug Sales in Value by Region: 2017-2022 5.3.2 Global Eye Drug Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Eye Drug Market Size YoY Growth 2017-2028 6.1.2 North America Eye Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Eye Drug Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Eye Drug Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Eye Drug Market Size YoY Growth 2017-2028 6.3.2 Europe Eye Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Eye Drug Market Size YoY Growth 2017-2028 6.4.2 Latin America Eye Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Eye Drug Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Eye Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Corporation Information 7.1.2 Pfizer Description and Business Overview 7.1.3 Pfizer Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Pfizer Eye Drug Products Offered 7.1.5 Pfizer Recent Development 7.2 Novartis 7.2.1 Novartis Corporation Information 7.2.2 Novartis Description and Business Overview 7.2.3 Novartis Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Novartis Eye Drug Products Offered 7.2.5 Novartis Recent Development 7.3 bausch Lomb 7.3.1 bausch Lomb Corporation Information 7.3.2 bausch Lomb Description and Business Overview 7.3.3 bausch Lomb Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.3.4 bausch Lomb Eye Drug Products Offered 7.3.5 bausch Lomb Recent Development 7.4 Laboratoire Riva 7.4.1 Laboratoire Riva Corporation Information 7.4.2 Laboratoire Riva Description and Business Overview 7.4.3 Laboratoire Riva Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Laboratoire Riva Eye Drug Products Offered 7.4.5 Laboratoire Riva Recent Development 7.5 Jamp Pharma 7.5.1 Jamp Pharma Corporation Information 7.5.2 Jamp Pharma Description and Business Overview 7.5.3 Jamp Pharma Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Jamp Pharma Eye Drug Products Offered 7.5.5 Jamp Pharma Recent Development 7.6 Fresenius 7.6.1 Fresenius Corporation Information 7.6.2 Fresenius Description and Business Overview 7.6.3 Fresenius Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Fresenius Eye Drug Products Offered 7.6.5 Fresenius Recent Development 7.7 Teva Pharmaceutical? 7.7.1 Teva Pharmaceutical? Corporation Information 7.7.2 Teva Pharmaceutical? Description and Business Overview 7.7.3 Teva Pharmaceutical? Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Teva Pharmaceutical? Eye Drug Products Offered 7.7.5 Teva Pharmaceutical? Recent Development 7.8 SANDOZ 7.8.1 SANDOZ Corporation Information 7.8.2 SANDOZ Description and Business Overview 7.8.3 SANDOZ Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.8.4 SANDOZ Eye Drug Products Offered 7.8.5 SANDOZ Recent Development 7.9 Greenstone 7.9.1 Greenstone Corporation Information 7.9.2 Greenstone Description and Business Overview 7.9.3 Greenstone Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Greenstone Eye Drug Products Offered 7.9.5 Greenstone Recent Development 7.10 Mylan 7.10.1 Mylan Corporation Information 7.10.2 Mylan Description and Business Overview 7.10.3 Mylan Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Mylan Eye Drug Products Offered 7.10.5 Mylan Recent Development 7.11 GE Medical 7.11.1 GE Medical Corporation Information 7.11.2 GE Medical Description and Business Overview 7.11.3 GE Medical Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.11.4 GE Medical Eye Drug Products Offered 7.11.5 GE Medical Recent Development 7.12 Mint Pharmaceuticals 7.12.1 Mint Pharmaceuticals Corporation Information 7.12.2 Mint Pharmaceuticals Description and Business Overview 7.12.3 Mint Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Mint Pharmaceuticals Products Offered 7.12.5 Mint Pharmaceuticals Recent Development 7.13 Laboratoires Thea 7.13.1 Laboratoires Thea Corporation Information 7.13.2 Laboratoires Thea Description and Business Overview 7.13.3 Laboratoires Thea Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Laboratoires Thea Products Offered 7.13.5 Laboratoires Thea Recent Development 7.14 Taj Pharmaceuticals 7.14.1 Taj Pharmaceuticals Corporation Information 7.14.2 Taj Pharmaceuticals Description and Business Overview 7.14.3 Taj Pharmaceuticals Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Taj Pharmaceuticals Products Offered 7.14.5 Taj Pharmaceuticals Recent Development 7.15 Actavis 7.15.1 Actavis Corporation Information 7.15.2 Actavis Description and Business Overview 7.15.3 Actavis Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Actavis Products Offered 7.15.5 Actavis Recent Development 7.16 APOTEX 7.16.1 APOTEX Corporation Information 7.16.2 APOTEX Description and Business Overview 7.16.3 APOTEX Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.16.4 APOTEX Products Offered 7.16.5 APOTEX Recent Development 7.17 Sun Pharma 7.17.1 Sun Pharma Corporation Information 7.17.2 Sun Pharma Description and Business Overview 7.17.3 Sun Pharma Eye Drug Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Sun Pharma Products Offered 7.17.5 Sun Pharma Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Eye Drug Industry Chain Analysis 8.2 Eye Drug Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Eye Drug Distributors 8.3 Eye Drug Production Mode & Process 8.4 Eye Drug Sales and Marketing 8.4.1 Eye Drug Sales Channels 8.4.2 Eye Drug Distributors 8.5 Eye Drug Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Eye Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Eye Drug Market Trends Table 3. Eye Drug Market Drivers Table 4. Eye Drug Market Challenges Table 5. Eye Drug Market Restraints Table 6. Global Eye Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Eye Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Eye Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Eye Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Eye Drug Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Eye Drug Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Eye Drug Revenue Share by Manufacturer, 2017-2022 Table 13. Global Eye Drug Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Eye Drug Sales Share by Manufacturer, 2017-2022 Table 15. Global Eye Drug Price by Manufacturer (2017-2022) & (USD/Kg) Table 16. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Eye Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drug as of 2021) Table 18. Top Players of Eye Drug in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Eye Drug Product Type Table 20. Date of International Manufacturers Enter into Eye Drug Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Eye Drug Players in United States Market, Ranking by Revenue (2021) Table 23. United States Eye Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Eye Drug Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Eye Drug Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Eye Drug Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Eye Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Eye Drug Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Eye Drug Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Eye Drug Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Eye Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Eye Drug Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Eye Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Eye Drug Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Eye Drug Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Eye Drug Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Eye Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Eye Drug Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Eye Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Eye Drug Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Eye Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Pfizer Corporation Information Table 43. Pfizer Description and Business Overview Table 44. Pfizer Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 45. Pfizer Eye Drug Product Table 46. Pfizer Recent Development Table 47. Novartis Corporation Information Table 48. Novartis Description and Business Overview Table 49. Novartis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 50. Novartis Product Table 51. Novartis Recent Development Table 52. bausch Lomb Corporation Information Table 53. bausch Lomb Description and Business Overview Table 54. bausch Lomb Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 55. bausch Lomb Product Table 56. bausch Lomb Recent Development Table 57. Laboratoire Riva Corporation Information Table 58. Laboratoire Riva Description and Business Overview Table 59. Laboratoire Riva Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 60. Laboratoire Riva Product Table 61. Laboratoire Riva Recent Development Table 62. Jamp Pharma Corporation Information Table 63. Jamp Pharma Description and Business Overview Table 64. Jamp Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 65. Jamp Pharma Product Table 66. Jamp Pharma Recent Development Table 67. Fresenius Corporation Information Table 68. Fresenius Description and Business Overview Table 69. Fresenius Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 70. Fresenius Product Table 71. Fresenius Recent Development Table 72. Teva Pharmaceutical? Corporation Information Table 73. Teva Pharmaceutical? Description and Business Overview Table 74. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 75. Teva Pharmaceutical? Product Table 76. Teva Pharmaceutical? Recent Development Table 77. SANDOZ Corporation Information Table 78. SANDOZ Description and Business Overview Table 79. SANDOZ Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 80. SANDOZ Product Table 81. SANDOZ Recent Development Table 82. Greenstone Corporation Information Table 83. Greenstone Description and Business Overview Table 84. Greenstone Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 85. Greenstone Product Table 86. Greenstone Recent Development Table 87. Mylan Corporation Information Table 88. Mylan Description and Business Overview Table 89. Mylan Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 90. Mylan Product Table 91. Mylan Recent Development Table 92. GE Medical Corporation Information Table 93. GE Medical Description and Business Overview Table 94. GE Medical Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 95. GE Medical Product Table 96. GE Medical Recent Development Table 97. Mint Pharmaceuticals Corporation Information Table 98. Mint Pharmaceuticals Description and Business Overview Table 99. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 100. Mint Pharmaceuticals Product Table 101. Mint Pharmaceuticals Recent Development Table 102. Laboratoires Thea Corporation Information Table 103. Laboratoires Thea Description and Business Overview Table 104. Laboratoires Thea Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 105. Laboratoires Thea Product Table 106. Laboratoires Thea Recent Development Table 107. Taj Pharmaceuticals Corporation Information Table 108. Taj Pharmaceuticals Description and Business Overview Table 109. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 110. Taj Pharmaceuticals Product Table 111. Taj Pharmaceuticals Recent Development Table 112. Actavis Corporation Information Table 113. Actavis Description and Business Overview Table 114. Actavis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 115. Actavis Product Table 116. Actavis Recent Development Table 117. APOTEX Corporation Information Table 118. APOTEX Description and Business Overview Table 119. APOTEX Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 120. APOTEX Product Table 121. APOTEX Recent Development Table 122. Sun Pharma Corporation Information Table 123. Sun Pharma Description and Business Overview Table 124. Sun Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 125. Sun Pharma Product Table 126. Sun Pharma Recent Development Table 127. Key Raw Materials Lists Table 128. Raw Materials Key Suppliers Lists Table 129. Eye Drug Customers List Table 130. Eye Drug Distributors List Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Eye Drug Product Picture Figure 2. Global Eye Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Eye Drug Market Size 2017-2028 (US$ Million) Figure 4. Global Eye Drug Sales 2017-2028 (MT) Figure 5. United States Eye Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Eye Drug Market Size 2017-2028 (US$ Million) Figure 7. United States Eye Drug Sales 2017-2028 (MT) Figure 8. United States Eye Drug Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Eye Drug Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Eye Drug Report Years Considered Figure 11. Product Picture of Drops Figure 12. Product Picture of Tablet & Capsule Figure 13. Global Eye Drug Market Share by Type in 2022 & 2028 Figure 14. Global Eye Drug Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Eye Drug Sales Market Share in Value by Type (2017-2028) Figure 16. Global Eye Drug Sales by Type (2017-2028) & (MT) Figure 17. Global Eye Drug Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Eye Drug Price by Type (2017-2028) & (USD/Kg) Figure 19. United States Eye Drug Market Share by Type in 2022 & 2028 Figure 20. United States Eye Drug Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Eye Drug Sales Market Share in Value by Type (2017-2028) Figure 22. United States Eye Drug Sales by Type (2017-2028) & (MT) Figure 23. United States Eye Drug Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Eye Drug Price by Type (2017-2028) & (USD/Kg) Figure 25. Product Picture of Glaucoma Figure 26. Product Picture of Retinal Disease Figure 27. Product Picture of Bacterial?Infection Figure 28. Product Picture of Other Figure 29. Global Eye Drug Market Share by Application in 2022 & 2028 Figure 30. Global Eye Drug Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Eye Drug Sales Market Share in Value by Application (2017-2028) Figure 32. Global Eye Drug Sales by Application (2017-2028) & (MT) Figure 33. Global Eye Drug Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Eye Drug Price by Application (2017-2028) & (USD/Kg) Figure 35. United States Eye Drug Market Share by Application in 2022 & 2028 Figure 36. United States Eye Drug Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Eye Drug Sales Market Share in Value by Application (2017-2028) Figure 38. United States Eye Drug Sales by Application (2017-2028) & (MT) Figure 39. United States Eye Drug Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Eye Drug Price by Application (2017-2028) & (USD/Kg) Figure 41. North America Eye Drug Sales in Volume Growth Rate 2017-2028 (MT) Figure 42. North America Eye Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Eye Drug Sales in Volume Growth Rate 2017-2028 (MT) Figure 46. Europe Eye Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Eye Drug Sales in Volume Growth Rate 2017-2028 (MT) Figure 53. Asia-Pacific Eye Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Eye Drug Sales in Volume Growth Rate 2017-2028 (MT) Figure 65. Latin America Eye Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Eye Drug Sales in Volume Growth Rate 2017-2028 (MT) Figure 70. Middle East & Africa Eye Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Eye Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Eye Drug Value Chain Figure 75. Eye Drug Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Pfizer Novartis bausch Lomb Laboratoire Riva Jamp Pharma Fresenius Teva Pharmaceutical? SANDOZ Greenstone Mylan GE Medical Mint Pharmaceuticals Laboratoires Thea Taj Pharmaceuticals Actavis APOTEX Sun Pharma